One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

Wijmeersch B Van; T Harrower; J Hobart; R Kizlaitiene; GA Marfia; F Patti; OR Pearson; Pesch V Van; P Vanderdonckt; L Vecsei; S Shor; A Achiron

doi:10.1111/ene.14308

One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

Wijmeersch B Van, T Harrower, J Hobart, R Kizlaitiene, GA Marfia, F Patti, OR Pearson, Pesch V Van, P Vanderdonckt, L Vecsei, S Shor, A Achiron

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1111/ene.14308
Publication status	Published - May 2020

Access to Document

10.1111/ene.14308

Cite this

@conference{1be873fe7d774926afe58051bdc00b6a,

title = "One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)",

author = "Van, {Wijmeersch B} and T Harrower and J Hobart and R Kizlaitiene and GA Marfia and F Patti and OR Pearson and Van, {Pesch V} and P Vanderdonckt and L Vecsei and S Shor and A Achiron",

year = "2020",

month = may,

doi = "10.1111/ene.14308",

language = "English",

}

TY - CONF

T1 - One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

AU - Van, Wijmeersch B

AU - Harrower, T

AU - Hobart, J

AU - Kizlaitiene, R

AU - Marfia, GA

AU - Patti, F

AU - Pearson, OR

AU - Van, Pesch V

AU - Vanderdonckt, P

AU - Vecsei, L

AU - Shor, S

AU - Achiron, A

PY - 2020/5

Y1 - 2020/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000534616803153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

U2 - 10.1111/ene.14308

DO - 10.1111/ene.14308

M3 - Conference paper (not formally published)

ER -

One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)

Access to Document

Other files and links

Cite this